Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Class A and Class B Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2024   273,265,000        
Beginning balance (in shares) at Jan. 31, 2024       14,131,000    
Beginning balance at Jan. 31, 2024 $ 679,704 $ 8 $ 1,182,150 $ (23,831) $ (3,836) $ (474,787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 45,252   45,252      
Exercise of stock options and vesting of restricted stock units (in shares)   6,039,000        
Exercise of stock options and vesting of restricted stock units 18,919   18,919      
Issuance of common shares upon ESPP purchases (in shares)   455,000        
Issuance of common shares upon ESPP purchases 3,403   3,403      
Common stock repurchased, including accrued excise tax (in shares)   (25,460,000)        
Common stock repurchased, including accrued excise tax (272,989)         (272,989)
Other comprehensive (loss) income (195)       (195)  
Net income 22,930         22,930
Ending balance (in shares) at Oct. 31, 2024   254,299,000        
Ending balance (in shares) at Oct. 31, 2024       14,131,000    
Ending balance at Oct. 31, 2024 497,024 $ 8 1,249,724 $ (23,831) (4,031) (724,846)
Beginning balance (in shares) at Jul. 31, 2024   253,366,000        
Beginning balance (in shares) at Jul. 31, 2024       14,131,000    
Beginning balance at Jul. 31, 2024 468,967 $ 8 1,232,417 $ (23,831) (4,251) (735,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 15,623   15,623      
Exercise of stock options and vesting of restricted stock units (in shares)   933,000        
Exercise of stock options and vesting of restricted stock units 1,684   1,684      
Common stock repurchased, including accrued excise tax (in shares)   0        
Common stock repurchased, including accrued excise tax 75         75
Other comprehensive (loss) income 220       220  
Net income 10,455         10,455
Ending balance (in shares) at Oct. 31, 2024   254,299,000        
Ending balance (in shares) at Oct. 31, 2024       14,131,000    
Ending balance at Oct. 31, 2024 $ 497,024 $ 8 1,249,724 $ (23,831) (4,031) (724,846)
Beginning balance (in shares) at Jan. 31, 2025   255,443,000        
Beginning balance (in shares) at Jan. 31, 2025 14,130,784     14,131,000    
Beginning balance at Jan. 31, 2025 $ 612,063 $ 8 1,268,920 $ (23,831) (6,969) (626,065)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 64,917   64,917      
Exercise of stock options and vesting of restricted stock units (in shares)   7,574,000        
Exercise of stock options and vesting of restricted stock units 13,884   13,884      
Issuance of common shares upon ESPP purchases (in shares)   412,000        
Issuance of common shares upon ESPP purchases 2,785   2,785      
Common stock repurchased, including accrued excise tax (in shares)   (17,617,000)        
Common stock repurchased, including accrued excise tax (151,342) $ (1)       (151,341)
Other comprehensive (loss) income 1,827       1,827  
Net income $ 13,951         13,951
Ending balance (in shares) at Oct. 31, 2025   245,812,000        
Ending balance (in shares) at Oct. 31, 2025 14,130,784     14,131,000    
Ending balance at Oct. 31, 2025 $ 558,085 $ 7 1,350,506 $ (23,831) (5,142) (763,455)
Beginning balance (in shares) at Jul. 31, 2025   245,102,000        
Beginning balance (in shares) at Jul. 31, 2025       14,131,000    
Beginning balance at Jul. 31, 2025 543,437 $ 7 1,328,449 $ (23,831) (4,742) (756,446)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 21,112   21,112      
Exercise of stock options and vesting of restricted stock units (in shares)   1,832,000        
Exercise of stock options and vesting of restricted stock units 945   945      
Common stock repurchased, including accrued excise tax (in shares)   (1,122,000)        
Common stock repurchased, including accrued excise tax (9,913)         (9,913)
Other comprehensive (loss) income (400)       (400)  
Net income $ 2,904         2,904
Ending balance (in shares) at Oct. 31, 2025   245,812,000        
Ending balance (in shares) at Oct. 31, 2025 14,130,784     14,131,000    
Ending balance at Oct. 31, 2025 $ 558,085 $ 7 $ 1,350,506 $ (23,831) $ (5,142) $ (763,455)